Paul Audhya

Chief Tech/Sci/R&D Officer chez KALVISTA PHARMACEUTICALS, INC.

Fortune : 627 228 $ au 31/03/2024

51 ans

Health Technology

Consumer Services

Postes actifs de Paul Audhya

Sociétés	Poste	Début	Fin
KALVISTA PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	03/05/2021	-

Sociétés	Poste	Début	Fin
ARENA PHARMACEUTICALS	Corporate Officer/Principal	26/11/2018	01/03/2021
VERTEX PHARMACEUTICALS INCORPORATED	Chief Tech/Sci/R&D Officer	01/02/2016	01/09/2018
HOSPIRA, INC.	Chief Tech/Sci/R&D Officer	01/06/2013	01/02/2016
REATA PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	04/07/2011	-

New York University	Undergraduate Degree
Pepperdine University	Masters Business Admin

Internationale

Etats-Unis

Opérationnelle

Chief Tech/Sci/R&D Officer	4
Undergraduate Degree	1
Corporate Officer/Principal	1

Sectorielle

Health Technology	6
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology
KALVISTA PHARMACEUTICALS, INC.	Health Technology

Entreprise privées	3
Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT.	Health Technology
Hospira, Inc. Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL.	Health Technology
Reata Pharmaceuticals, Inc. Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX.	Health Technology